Myeloma UK Award to Manchester Royal Infirmary Haemotology Department Manchester University NHS Foundation Trust - 01 May 2024 Myeloma UK Award to Manchester Royal Infirmary Haemotology Department ... More
Managing Cranial Nerve Impairment in Multiple Myeloma Following Cilta-cel Cancer Network - 01 May 2024 Managing Cranial Nerve Impairment in Multiple Myeloma Following Cilta-cel ... More
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach | Leukemia Nature - 30 Apr 2024 Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach | Leukemia ... More
Multiple Myeloma: What's a Therapy 'Line'? HealthTree - 29 Apr 2024 Multiple Myeloma: What's a Therapy 'Line'? ... More
Clinical Benefits, But Not Improved ORR, Seen With KPd in Lenalidomide-Refractory Multiple Myeloma Hematology Advisor - 01 May 2024 Clinical Benefits, But Not Improved ORR, Seen With KPd in Lenalidomide-Refractory Multiple Myeloma ... More
Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma OncLive - 29 Apr 2024 Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma ... More
15th International Myeloma Foundation gala raises over $675K Myeloma Research News - 30 Apr 2024 15th International Myeloma Foundation gala raises over $675K ... More
Daratumumab Plus Standard Therapy for Multiple Myeloma National Cancer Institute (.gov) - 19 Jan 2024 Daratumumab Plus Standard Therapy for Multiple Myeloma ... More
Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma Oncology Nursing News - 27 Apr 2024 Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma ... More
Mayo Clinic Minute: Advances in multiple myeloma treatment Mayo Clinic - 12 Mar 2024 Mayo Clinic Minute: Advances in multiple myeloma treatment ... More
New study points to racial and social barriers that block treatment for multiple myeloma UC Davis Health - 23 Apr 2024 New study points to racial and social barriers that block treatment for multiple myeloma ... More
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ... Nature - 22 Apr 2024 Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ... ... More
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy OncLive - 22 Apr 2024 European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy ... More
What Is a FISH Test in Multiple Myeloma? HealthTree - 22 Apr 2024 What Is a FISH Test in Multiple Myeloma? ... More
Rheological properties of blood in multiple myeloma patients | Scientific Reports Nature - 21 Feb 2024 Rheological properties of blood in multiple myeloma patients | Scientific Reports ... More
The enduring neutrophil–stroma dance of multiple myeloma Nature - 10 Apr 2024 The enduring neutrophil–stroma dance of multiple myeloma ... More
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ... Nature - 15 Apr 2024 In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ... ... More
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal Nature - 25 Jan 2024 Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review | Blood Cancer Journal ... More
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal Nature - 05 Mar 2024 Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal ... More